ClinicalTrials.gov
ClinicalTrials.gov Menu

Cartilage Tissue Engineering

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01301664
Recruitment Status : Available
First Posted : February 23, 2011
Last Update Posted : March 7, 2013
Sponsor:
Information provided by (Responsible Party):
Chin-Hung Chang, Far Eastern Memorial Hospital

Study Description
Go to 
Study Description Study Design Interventions Eligibility Criteria Contacts and Locations More Information
Brief Summary:

In this study, the investigators explored the hypothesis that osteoarthritic cartilage fragments can promote chondrogenesis of MSCs. Non-wearing parts of cartilage tissues were harvested from one osteoarthritic patient during the total knee arthroplasty surgery. Cartilage fragments and MSCs were wrapped into fibrin glue; and the constructs were implanted subcutaneously into nude mice.

Moreover, the investigators will collect the discard cartilage to develop an acellular cartilage ECM-derived scaffold in the joint replacement surgery. In addition, the investigators will harvest the redundant bone marrow from drilling or useless synovium during the surgery to separate the mesenchymal stem cells. Furthermore, these mesenchymal stem cells will be transfected with hTERT for rejuvenation and then will be labeled with fluorescent dye PKH26 for application of animal study. To sum up, the investigators plan to use human, natural, and discard materials from the joint replacement surgery to develop appropriate allograft for cartilage repair and hope that one day this ideal would be apply in clinical.


Condition or disease Intervention/treatment
Mesenchymal Stem Cells Other: total knee / hip replacement

Detailed Description:
Extracellular matrix (ECM) is thought to participate significantly in guiding the differentiation process of mesenchymal stem cells (MSCs). In this study, we explored the hypothesis that osteoarthritic cartilage matrix can promote chondrogenesis of MSCs. Cartilage matrix was harvested from the health-like parts of osteoarthritic cartilage tissue. Cartilage fragments and MSCs were wrapped into fibrin glue; and the constructs were implanted subcutaneously into nude mice. Histological analysis showed a round and elongated cell appearance with positive Alcian blue staining of cartilage matrix formation in the constructs. However, the cells in fibrin glue only were condensed like MSCs in pellet culture. Immunohistochemical staining was abundantly positive for type II collagen in neo-cartilage regions of cartilage fragment-fibrin glue-MSC constructs, while the constructs without cartilage fragments were negative in staining for type II collagen. The gene expressions of type II collagen in the constructs with 60 mg fragments were significantly elevated after 4 weeks of implantation. Conversely, constructs without cartilage fragments failed to express type II collagen, which indicated that MSCs could not differentiate into a chondrogenic lineage. In conclusion, we demonstrated the effects of osteoarthritic cartilage matrix in promoting chondrogenic differentiation of MSCs. This was a favorable method without exogenous growth factors induction.

Study Design
Go to 
Study Description Study Design Interventions Eligibility Criteria Contacts and Locations More Information

Study Type : Expanded Access
Interventions
Go to 
Study Description Study Design Interventions Eligibility Criteria Contacts and Locations More Information

Intervention Details:
    Other: total knee / hip replacement
    Human cartilage tissues were harvested from osteoarthritic patient during total knee arthroplasty surgery.
Eligibility Criteria
Go to 
Study Description Study Design Interventions Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   30 Years to 70 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Criteria

Inclusion Criteria:

  • 30-70 years old

Exclusion Criteria:

  • more than 70 years old
Contacts and Locations
Go to 
Study Description Study Design Interventions Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01301664


Contacts
Contact: Chia-Chun Chen, Master chia_chun_@hotmail.com

Sponsors and Collaborators
Chin-Hung Chang
More Information
Go to 
Study Description Study Design Interventions Eligibility Criteria Contacts and Locations More Information

Responsible Party: Chin-Hung Chang, MD.PhD., Far Eastern Memorial Hospital
ClinicalTrials.gov Identifier: NCT01301664     History of Changes
Other Study ID Numbers: 97022
First Posted: February 23, 2011    Key Record Dates
Last Update Posted: March 7, 2013
Last Verified: March 2013

Keywords provided by Chin-Hung Chang, Far Eastern Memorial Hospital:
The bone marrow-derived mesenchymal stem cells (BMMSCs) were obtained from redundant bone marrow from drilling during the joint replacement surgery.
The synovial-derived mesenchymal stem cells (SMSCs) were isolated from synovial membranes in the joint replacement surgery.
Cartilage slices were obtained from discard cartilage in the joint replacement surgery.